Bioengineering & Translational Medicine is a peer-reviewed english-language open-access journal published by Wiley in United States, operating under an open-access model since 2016. The journal covers Chemical technology: Chemical engineering, Therapeutics. Pharmacology, and Chemical technology: Biotechnology.
Authors are required to pay an article processing charge to publish in Bioengineering & Translational Medicine; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, Bioengineering & Translational Medicine has published 938 articles. Articles are minted with DOIs through the prefix 10.1002. All submissions undergo plagiarism screening before peer review.
Keywords
drug delivery, tissue engineering, synthetic biology, biosensors, biomolecular engineering, immunotherapy
At a glance
- Publisher
- Wiley
- Country
- United States
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Peer review, Anonymous peer review
- OA since
- 2016
- Review time
- 12 weeks
- DOI prefix
10.1002- Plagiarism check
- Yes
ISSN
- electronic
- 2380-6761
Frequently asked questions
Is Bioengineering & Translational Medicine peer-reviewed?
Does Bioengineering & Translational Medicine charge an article processing charge (APC)?
What subjects does Bioengineering & Translational Medicine publish?
What languages does Bioengineering & Translational Medicine accept?
What is the ISSN of Bioengineering & Translational Medicine?
2380-6761 (electronic).